ArticleJournal of cancer research and clinical oncology2021

Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation.

Yu-Jin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.